TWO · Healthcare

MegaPro Biomedical Co., Ltd (6827)

Biotechnology

MegaPro Biomedical Co., Ltd (6827) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6827

P/E ratio

25.00

MegaPro Biomedical Co., Ltd (6827) — FAQ

What is 6827's P/E ratio?

The price-to-earnings (P/E) ratio for MegaPro Biomedical Co., Ltd (6827) is 25.00 (data as of 2026-05-23).

Does MegaPro Biomedical Co., Ltd pay a dividend?

Dividend yield is not available in the current snapshot for MegaPro Biomedical Co., Ltd (6827). Check the MyAverix Finance app for the latest dividend data.

What sector is MegaPro Biomedical Co., Ltd in?

MegaPro Biomedical Co., Ltd (6827) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6827 listed on?

6827 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)